Target intelligence / Profile preview

ATP-binding cassette sub-family D member 3 (ABCD3)

Target
ABCD3
Molecular classification
Transporter, ABC transporter (specifically: ATP-binding cassette transporter, sub-family D, ALD subfamily), Peroxisomal membrane protein
01

Overview

ATP-binding cassette sub-family D member 3 (ABCD3, also known as PMP70) is a peroxisomal membrane transporter belonging to the ABC transporter superfamily[1][4]. It mediates peroxisomal import of specific fatty acyl-CoAs, including long-chain and branched-chain fatty acids, dicarboxylic fatty acids, and bile acid precursors, facilitating their subsequent β-oxidation in the peroxisome[1][2][4][5]. Structurally, ABCD3 is a half-transporter that forms functional homo- or heterodimers in the peroxisomal membrane[3][4]. Mutations in ABCD3 can lead to peroxisomal metabolic disorders, including rare cases of congenital bile acid synthesis defect and potentially contribute to the spectrum of Zellweger syndrome[1][2][4]. The protein plays a critical role in maintaining lipid metabolic balance and peroxisome function within cells[2][4]. No approved or clinically established drugs specifically target ABCD3, and its main human disease links are genetic in nature.

Other names
ATP-binding cassette sub-family D member 3PMP70PXMP1ZWS270 kDa peroxisomal membrane proteinperoxisomal membrane protein 70 kDaABC43CBAS5peroxisomal membrane protein-1 (70kD)peroxisomal membrane protein 1 (70kD, Zellweger syndrome)
02

Biological functions

Peroxisomal import of fatty acids and fatty acyl-CoAsLipid homeostasisPeroxisomal β-oxidation (breakdown of long and branched chain fatty acids, dicarboxylic fatty acids, and bile acid precursors)Peroxisome biogenesis
03

Disease associations

Peroxisomal disorders (e.g., Zellweger syndrome spectrum)Congenital bile acid synthesis defect-5 (CBAS5)Severe liver disease/hepatosplenomegalyLipid metabolism disorders (lipodystrophy, abnormal bile acid profiles)
04

Safety considerations

Possible peroxisomal dysfunction with loss of ABCD3 functionLiver toxicity/hepatosplenomegaly in the context of ABCD3 deficiencyLipid homeostasis disruption
05

Biomarkers

Accumulation of dicarboxylic fatty acids or bile acid intermediates in plasma/urineHepatic long-chain dicarboxylic acids elevationIncreased plasma DHCA and THCA in ABCD3 deficiency

Beyond the preview

Go deeper on ATP-binding cassette sub-family D member 3 (ABCD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family D member 3 (ABCD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call